Serum antibodies against native and denaturated hemagglutinin glycoproteins detected by ELISA as correlates of protection after influenza vaccination in healthy vaccinees and in kidney transplant recipients

Journal of Virological Methods

Volumn 193, Issue 2, 2013, Pages 558-564

  Grund, S ^a   Pietzonka, S ^a   Michel, S ^a   Adams, O ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ELISA; Influenza virus; Kidney transplant recipients; Neutralization assay; Vaccination

Indexed keywords

FETUIN; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; RECOMBINANT ANTIBODY; VIRUS ANTIBODY; VIRUS GLYCOPROTEIN;

2009 H1N1 INFLUENZA; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAFT RECIPIENT; HUMAN; INFECTION PREVENTION; INFLUENZA VACCINATION; KIDNEY TRANSPLANTATION; LINKAGE ANALYSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; VIRUS NEUTRALIZATION;

ELISA; INFLUENZA VIRUS; KIDNEY TRANSPLANT RECIPIENTS; NEUTRALIZATION ASSAY; VACCINATION;

ADULT; AGED; ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTHY VOLUNTEERS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOGLOBULIN G; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROTEIN DENATURATION; SENSITIVITY AND SPECIFICITY; TRANSPLANTATION;

EID: 84882980898     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.07.032     Document Type: Article

References (21)

1. Brakemeier S., Schweiger B., Lachmann N., Glander P., Schonemann C., Diekmann F., Neumayer H.H., Budde K. Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix((R))) in renal transplant recipients. Nephrology Dialysis Transplantation 2012, 27:423-428.
2. Broeders N.E., Hombrouck A., Lemy A., Wissing K.M., Racape J., Gastaldello K., Massart A., Van Gucht S., Weichselbaum L., De Mul A., Brochier B., Thomas I., Abramowicz D. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clinical Journal of the American Society of Nephrology 2011, 6:2573-2578.
3. Brokstad K.A., Cox R.J., Major D., Wood J.M., Haaheim L.R. Cross-reaction but no avidity change of the serum antibody response after influenza vaccination. Vaccine 1995, 13:1522-1528.
4. Brokstad K.A., Cox R.J., Olofsson J., Jonsson R., Haaheim L.R. Parenteral influenza vaccination induces a rapid systemic and local immune response. The Journal of Infectious Diseases 1995, 171:198-203.
5. El-Madhun A.S., Cox R.J., Haaheim L.R. The effect of age and natural priming on the IgG and IgA subclass responses after parenteral influenza vaccination. The Journal of Infectious Diseases 1999, 180:1356-1360.
6. Feng J., Gulati U., Zhang X., Keitel W.A., Thompson D.M., James J.A., Thompson L.F., Air G.M. Antibody quantity versus quality after influenza vaccination. Vaccine 2009, 27:6358-6362.
7. Green N., Alexander H., Olson A., Alexander S., Shinnick T.M., Sutcliffe J.G., Lerner R.A. Immunogenic structure of the influenza virus hemagglutinin. Cell 1982, 28:477-487.
8. Grund S., Adams O., Wahlisch S., Schweiger B. Comparison of hemagglutination inhibition assay, an ELISA-based micro-neutralization assay and colorimetric microneutralization assay to detect antibody responses to vaccination against influenza A H1N1 2009 virus. Journal of Virological Methods 2011, 171:369-373.
9. Gulati U., Kumari K., Wu W., Keitel W.A., Air G.M. Amount and avidity of serum antibodies against native glycoproteins and denatured virus after repeated influenza whole-virus vaccination. Vaccine 2005, 23:1414-1425.
10. Hansen A., Grund S., Hetzel G., Ivens K., Summchen H.A., Zgoura P., Hengel H., Adams O., Rump L.C. Noncontrolled trial of monovalent AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) in long-term dialysis patients and transplant recipients. American Journal of Kidney Diseases 2012, 59:471-473.
11. Knossow M., Gaudier M., Douglas A., Barrere B., Bizebard T., Barbey C., Gigant B., Skehel J.J. Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 2002, 302:294-298.
12. Kunisaki K.M., Janoff E.N. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. The Lancet Infectious Diseases 2009, 9:493-504.
13. Laver W.G., Air G.M., Webster R.G., Smith-Gill S.J. Epitopes on protein antigens: misconceptions and realities. Cell 1990, 61:553-556.
14. Lenette H.L., Schmidt N.J. Influenza viruses. Diagnostic Procedures for Viral Rickettsial and Chlamydial Infections 1979, 585-609.
15. Powers D.C. Effect of age on serum immunoglobulin G subclass antibody responses to inactivated influenza virus vaccine. Journal of Medical Virology 1994, 43:57-61.
16. Quintana L.F., Serra N., De Molina-Llaurado P., Blasco M., Martinez M., Campos B., Bayas J.M., Pumarola T., Campistol J.M. Influence of renal replacement therapy on immune response after one and two doses of the A(H1N1) pdm09 vaccine. Influenza and Other Respiratory Viruses 2012.
17. Remarque E.J., van Beek W.C., Ligthart G.J., Borst R.J., Nagelkerken L., Palache A.M., Sprenger M.J., Masurel N. Improvement of the immunoglobulin subclass response to influenza vaccine in elderly nursing-home residents by the use of high-dose vaccines. Vaccine 1993, 11:649-654.
18. Rowe T., Abernathy R.A., Hu-Primmer J., Thompson W.W., Lu X., Lim W., Fukuda K., Cox N.J., Katz J.M. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. Journal of Clinical Microbiology 1999, 37:937-943.
19. Stepanova L., Naykhin A., Kolmskog C., Jonson G., Barantceva I., Bichurina M., Kubar O., Linde A. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly. Journal of Clinical Virology 2002, 24:193-201.
20. White J.M., Wilson I.A. Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin. The Journal of Cell Biology 1987, 105:2887-2896.
21. WHO Laboratory Biorisk Management for Laboratories Handling Human Specimens Suspected or Confirmed to Contain Influenza A (H1N1) Causing the Current International Epidemics 2009, http://proj1.sinica.edu.tw/~biosafe/WHO_H1N1_lab_biorisk_manage.pdf.